未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Impact of primary tumor sidedness and sex on prognosis and anti-epidermal growth factor receptor antibody efficacy in BRAF-mutant metastatic colorectal cancer: a pooled analysis of AIO studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI Alig, A. H. S.; Modest, D. P.; Stintzing, S.; Heinrich, K.; Geissler, M.; von Weikersthal, L. Fischer; Decker, T.; Vehling-Kaiser, U.; Held, S.; Moosmann, N.; Stahler, A.; Tannapfel, A.; Giessen-Jung, C.; Jung, A.; Weiss, L.; Heinemann, V. 分享 收藏
The role of trephine bone marrow biopsies in the era of measurable residual disease-Results from the CLL10 trial of the German CLL Study Group (GCLLSG) Kutsch, Nadine; Robrecht, Sandra; Fink, Anna; Lange, Elisabeth; Weide, Rudolf; Kiehl, Michael G.; Soekler, Martin; Schlag, Rudolf; Vehling-Kaiser, Ursula; Koechling, Georg; Ploeger, Christoph; Gregor, Michael; Plesner, Torben; Clausen, Michael R.; Oschlies, Ilske; Ritgen, Matthias; Herling, Marco; Fischer, Kirsten; Doehner, Hartmut; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Hallek, Michael; Boettcher, Sebastian; Klapper, Wolfram; Eichhorst, Barbara 分享 收藏
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial Al-Sawaf, Othman; Ligtvoet, Rudy; Robrecht, Sandra; Stumpf, Janina; Fink, Anna-Maria; Tausch, Eugen; Schneider, Christof; Boettcher, Sebastian; Mikusko, Martin; Ritgen, Matthias; Schetelig, Johannes; von Tresckow, Julia; Vehling-Kaiser, Ursula; Gaska, Tobias; Wendtner, Clemens Martin; Chapuy, Bjoern; Fischer, Kirsten; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Staber, Philipp; Niemann, Carsten; Hallek, Michael; Eichhorst, Barbara 分享 收藏
The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer Ohnmacht, Alexander J.; Stahler, Arndt; Stintzing, Sebastian; Modest, Dominik P.; Holch, Julian W.; Westphalen, C. Benedikt; Hoelzel, Linus; Schuebel, Marisa K.; Galhoz, Ana; Farnoud, Ali; Ud-Dean, Minhaz; Vehling-Kaiser, Ursula; Decker, Thomas; Moehler, Markus; Heinig, Matthias; Heinemann, Volker; Menden, Michael P. 分享 收藏
Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in Germany Kroening, Hendrik; Goehler, Thomas; Decker, Thomas; Grundeis, Marc; Kojouharoff, Georgi; Lipke, Joerg; Semsek, Dieter; Moorahrend, Enno; Sauer, Annette; Bruch, Harald-Robert; Liersch, Ruediger; Nusch, Arnd; Vehling-Kaiser, Ursula; Welslau, Manfred; Grunewald, Ralf; Harich, Hanns-Detlev; Stephany, Marcel; Uhlig, Jens; de Buhr, Rebecca; Frank, Melanie; Hogrefe, Cathrin; Marschner, Norbert; Potthoff, Karin; Hartmann, Frank; Reislaender, Timo; Schwaner, Ingo 分享 收藏
Prognostic and predictive value of CEA before initiation of therapy in the XELAVIRI trial Alig, A.; Heinemann, V.; von Weikersthal, L. Fischer; Decker, T.; Vehling-Kaiser, U.; Uhlig, J.; Schenk, M.; Denzlinger, C.; Stahler, A.; Held, S.; Stintzing, S.; Modest, D.; Heinrich, K. 分享 收藏
Changes in the course of advanced pancreatic cancer treatment with systemic chemotherapy: A pooled analysis of five clinical trials from two decades of clinical research within the German AIO Study-Group Weiss, L.; Heinemann, V.; Fischer, L.; Gieseler, F.; Hoehler, T.; Mayerle, J.; Quietzsch, D.; Reinacher-Schick, A.; Schenk, M.; Seipelt, G.; Siveke, J.; Stahl, M.; Vehling-Kaiser, U.; Waldschmidt, D.; Dorman, K.; Zhang, D.; Westphalen, B.; Haas, M.; Boeck, S. 分享 收藏
Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial Weiss, L.; Karthaus, M.; Riera-Knorrenschild, J.; Kretzschmar, A.; Welslau, M.; Vehling-Kaiser, U.; Pelz, H.; Ettrich, T. J.; Hess, J.; Reislaender, T.; Klein, A.; Heinemann, V 分享 收藏
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry Al-Batran, Salah-Eddin; Hofheinz, Ralf-Dieter; Reichart, Alexander; Pauligk, Claudia; Schoenherr, Caroline; Schlag, Rudolf; Siegler, Gabriele; Doerfel, Steffen; Koenigsmann, Michael; Zahn, Mark-Oliver; Schubert, Joerg; Aldaoud, Ali; Hoeffkes, Heinz-Gert; Schulz, Holger; Hahn, Lars; Uhlig, Jens; Blau, Wolfgang; Stauch, Martina; Weniger, Joerg; Wolf, Martin; Jacobasch, Lutz; Bildat, Stephan; Wehmeyer, Juergen; Homann, Nils; Trojan, Joerg; Waidmann, Oliver; Fietz, Thomas; Feustel, Hans-Peter; Groschek, Matthias; Wierecky, Jan; Waibel, Karin; Mahlmann, Stefan; Schwindel, Uwe; Peters, Uwe; Schuch, Gunter; Pink, Daniel; Eschenburg, Henning; Woerns, Marcus-A.; Harich, Hans-Detlev; von Weikersthal, Ludwig Fischer; Daessler, Klaus-Ulrich; Behringer, Dirk M.; Messmann, Helmut; Kretzschmar, Albrecht; Gallmeier, Eike; Forstbauer, Helmut; Kunzmann, Volker; Papke, Jens; Buechner-Steudel, Petra; Vehling-Kaiser, Ursula; Springfeld, Christoph; Vogel, Arndt; Ettrich, Thomas J.; Schaaf, Marina; zur Hausen, Gerrit; Goetze, Thorsten Oliver 分享 收藏
Final results from IMPROVE: a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients' preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer Decker, Thomas; Soeling, Ulrike; Hahn, Antje; Maintz, Christoph; Kurbacher, Christian Martin; Vehling-Kaiser, Ursula; Sent, Dagmar; Klare, Peter; Hagen, Volker; Chiabudini, Marco; Falkenstein, Julia; Indorf, Martin; Runkel, Eva; Potthoff, Karin 分享 收藏
Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO) Cramer, Paula; von Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; Furstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; Durig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael 分享 收藏
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group Hoechstetter, Manuela A.; Busch, Raymonde; Eichhorst, Barbara; Buhler, Andreas; Winkler, Dirk; Bahlo, Jasmin; Robrecht, Sandra; Eckart, Michael J.; Vehling-Kaiser, Ursula; Jacobs, Georg; Jaeger, Ulrich; Hurtz, Hans Juergen; Hopfinger, Georg; Hartmann, Frank; Fuss, Harald; Abenhardt, Wolfgang; Blau, Ilona; Freier, Werner; Mueller, Lothar; Goebeler, Maria; Wendtner, Clemens; Fischer, Kirsten; Herling, Carmen D.; Starck, Michael; Bentz, Martin; Emmerich, Bertold; Doehner, Hartmut; Stilgenbauer, Stephan; Hallek, Michael 分享 收藏
Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG) Kutsch, Nadine; Bahlo, Jasmin; Robrecht, Sandra; Franklin, Jeremy; Zhang, Can; Maurer, Christian; De Silva, Nisha; Lange, Elisabeth; Weide, Rudolf; Kiehl, Michael G.; Soekler, Martin; Schlag, Rudolf; Vehling-Kaiser, Ursula; Koechling, Georg; Ploeger, Christoph; Gregor, Michael; Plesner, Torben; Herling, Marco; Fischer, Kirsten; Doehner, Hartmut; Kneba, Michael; Wendtner, Clemens-Martin; Klapper, Wolfram; Kreuzer, Karl-Anton; Boettcher, Sebastian; Stilgenbauer, Stephan; Fink, Anna Maria; Hallek, Michael; Eichhorst, Barbara 分享 收藏
Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) 基线癌胚抗原与FOLFIRI联合西妥昔单抗或贝伐单抗一线治疗转移性结直肠癌的相关性 (FIRE-3试验) Holch, J. W.; Ricard, I.; Stintzing, S.; von Weikersthal, L. Fischer; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Heintges, T.; Kahl, C.; Kullmann, F.; Scheithauer, W.; Moehler, M.; Jelas, I.; Modest, D. P.; Westphalen, C. B.; von Einem, J. C.; Michl, M.; Heinemann, V. 分享 收藏
Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial Holch, Julian Walter; Ricard, Ingrid; Stintzing, Sebastian; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmueller, Christian; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Scholz, Michael; Mueller, Sebastian; Link, Hartmut; Rost, Andreas; Hoeffkes, Heinz-Gert; Moehler, Markus; Lindig, Reinhard Udo; Miller-Phillips, Lisa; Kirchner, Thomas; Jung, Andreas; von Einem, Jobst Christian; Modest, Dominik Paul; Heinemann, Volker 分享 收藏
Evaluation of survival across several treatment lines in metastatic colorectal cancer: Analysis of the FIRE-3 trial (AIO KRK0306) Modest, D. P.; Ricard, I.; Stintzing, S.; von Weikersthal, L. Fischer; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Al-Batran, S-E.; Heintges, T.; Kahl, C.; Seipelt, G.; Kullmann, F.; Scheithauer, W.; Moehler, M.; Westphalen, C. B.; Holch, J. W.; von Einem, J. C.; Held, S.; Heinemann, V. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
BMC CANCER.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏